Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Cisatracurium Besylate NDC 0781-3152 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 01
image 02
This appears to be a numerical data related to a map, indicating different percentages at various coordinates or locations. However, without additional context or visual representation, it is not possible to draw any meaningful conclusions or provide a more specific description.*
image 03
This text appears to show some percentage increments and decrements related to human resources (HR). However, without additional context or information, it is difficult to determine the specific meaning or relevance of these percentages.*
image 04
This is a description of a drug called Cisatracurium Besylate Injection, USP. The drug is intended for intravenous injection and is used as a paralyzing agent. It comes in two strengths, 20mg/0mL and 20mg/10mL. The drug must be refrigerated and protected from light. Each mL of Cisatracurum Besylate contains bonzy alcohol 0.9% and War for Infciion USP. Additionally, the drug contains bonzenesulfonic aci s to adjust the ph value. It is manufactured by Gland Pharma Limited in India for Sandoz Inc. Princeton. The usual dosage of the drug is specified in the package insert. Warning issues: causes respiratory arrest and must be administered with the immediate availability of an artificial respiratory facility.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.